Incidence rate ratios for cancers in patients with T2DM using GLP-1 RA To evaluate the association between the use of GLP-1 RAs and cancer occurrence, we further analyzed the IRR of subsequent cancers in the GLP-1 RA and DM control groups (Fig
Strbe et al., 2021), intratracheal alcohol instillation (Stancic-Rokotov et al., 2001b), and pulmonary hypertension syndrome in chickens (Udovicic et al., 2021)
This means seeking solutions when problems are too often advanced, expensive, or too late to treat
As research progresses, regulated pharmaceutical development may eventually offer validated pathways for NNMT inhibitors
saxagliptin, sitagliptin) have been developed to inhibit the cleavage of GLP-1